Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

Document first published:
Page updated:
Topic:
Publication type:
NHS England will commission treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation in accordance with the criteria outlined in this document.

Document

Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

  • PDF
  • 129 KB
  • 7 pages

Summary

This document updates:

  • Clinical Commissioning Policy: Treatments for Graft versus Host Disease (GvHD) following Haematopoietic Stem Cell Transplantation (2017)

Document

EHIA: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

EHIA: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

  • PDF
  • 148 KB
  • 14 pages